Home
World Journal of Advanced Research and Reviews
International Journal with High Impact Factor for fast publication of Research and Review articles

Main navigation

  • Home
    • Journal Information
    • Editorial Board Members
    • Reviewer Panel
    • Abstracting and Indexing
    • Journal Policies
    • Our CrossMark Policy
    • Publication Ethics
    • Issue in Progress
    • Latest Issue Published
    • Past Issues
    • Instructions for Authors
    • Article processing fee
    • Track Manuscript Status
    • Get Publication Certificate
    • Join Editorial Board
    • Join Reviewer Panel
  • Contact us
  • Downloads

eISSN: 2581-9615 || CODEN: WJARAI || Impact Factor 8.2 ||  CrossRef DOI

Research and review articles are invited for publication in November 2026 (Volume 32, Issue 2) Submit manuscript

IMPLEMENTING ULCERATIVE COLITIS DIARY AND ENDOSCOPIC EFFICACY ENDPOINTS (A REPRODUCIBLE ADAM-ORIENTED FRAMEWORK AND SYNTHETIC-DATA SENSITIVITY STUDY)

Breadcrumb

  • Home
  • IMPLEMENTING ULCERATIVE COLITIS DIARY AND ENDOSCOPIC EFFICACY ENDPOINTS (A REPRODUCIBLE ADAM-ORIENTED FRAMEWORK AND SYNTHETIC-DATA SENSITIVITY STUDY)

Jyoti (Jo) Agarwal 1, * and Satyakam Singh 2

1 Gilead Sciences.
2 Bristol Myers Squibb (BMS). 
* Corresponding Author

Research Article

 

World Journal of Advanced Research and Reviews, 2021, 12(03), 820–830

Article DOI:10.30574/wjarr.2021.12.3.0703

DOI url: https://doi.org/10.30574/wjarr.2021.12.3.0703

Received on 11 November 2021; revised on 26 December 2021; accepted on 30 December 2021

Background: Ulcerative colitis (UC) trials integrate symptom diaries and endoscopic assessment, often under distinct visit windows and missingness rules. The SELECTION trial of filgotinib provides a published clinical context, but reproducible endpoint programming requires separate, auditable specifications. 
Objective: To present a component-first, ADaM-oriented implementation framework and experimentally assess the sensitivity of an illustrative UC remission classification to a change in diary eligibility. 
Methods: We specified source-to-analysis lineage, visit anchoring, component aggregation, endpoint construction and validation controls, informed by public clinical and regulatory literature. Using a fixed random seed (20261101), we generated 500 entirely synthetic profiles with seven preassessment diary days and artificial baseline and endoscopic subscores. For each symptom component, we required four valid diary days and applied round-half-up to the mean. Two scenarios retained all seven preceding days or omitted day −1, respectively. 
Results: Of 500 profiles, 491 were classifiable under both scenarios. Remission classification differed for 21/491 (4.3%); 92/491 (18.7%) met the illustrative remission condition with all days versus 89/491 (18.1%) after excluding day −1. Unclassifiable profiles numbered 1 and 9, respectively, among all 500. 
Conclusions: Altering diary eligibility can change derived classifications and evaluability in a constructed computational example. Results are not clinical estimates, a replication of SELECTION, or validation of a regulatory endpoint. The framework supports transparent rule testing and traceability prior to protocol-specific implementation.

Ulcerative Colitis, Mayo Score, Diary Data, Electronic Patient-Reported Outcomes; Endoscopy, Adam, Missing Data; Adam; Synthetic Data; Reprdoucibility; Sensitivity Analysis.

https://wjarr.com/sites/default/files/fulltext_pdf/WJARR-2021-0703.pdf

Preview Article PDF

Jyoti (Jo) Agarwal and Satyakam Singh. IMPLEMENTING ULCERATIVE COLITIS DIARY AND ENDOSCOPIC EFFICACY ENDPOINTS (A REPRODUCIBLE ADAM-ORIENTED FRAMEWORK AND SYNTHETIC-DATA SENSITIVITY STUDY). World Journal of Advanced Research and Reviews, 2021, 12(03), 820–830. Article DOI: https://doi.org/10.30574/wjarr.2021.12.3.0703

Copyright © Author(s). All rights reserved. This article is published under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits use, sharing, adaptation, distribution, and reproduction in any medium or format, as long as appropriate credit is given to the original author(s) and source, a link to the license is provided, and any changes made are indicated.


All statements, opinions, and data contained in this publication are solely those of the individual author(s) and contributor(s). The journal, editors, reviewers, and publisher disclaim any responsibility or liability for the content, including accuracy, completeness, or any consequences arising from its use.

Get Certificates

Get Publication Certificate

Download LoA

Check Corssref DOI details

Issue details

Issue Cover Page

Editorial Board

Table of content

Copyright © 2026 World Journal of Advanced Research and Reviews - All rights reserved

Developed & Designed by VS Infosolution